Related Experiment Video
Updated: Jun 3, 2025

12:55
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
Published on: January 17, 2015
18.5K
The Application of Machine Learning on Antibody Discovery and Optimization.
Jiayao Zheng1, Yu Wang2, Qianying Liang2
1School of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou 213164, China.
Molecules (Basel, Switzerland)
|January 8, 2025
Summary
Machine learning (ML) models are revolutionizing antibody discovery and optimization. These AI approaches significantly reduce time and cost compared to traditional methods, accelerating the development of new antibody therapeutics.
Area of Science:
- Biotechnology
- Computational Biology
- Immunology
Background:
- Antibodies are crucial in medicine for diagnostics and therapeutics.
- Traditional antibody discovery is slow and expensive.
- Advancements in data, hardware, and ML offer new possibilities.
Purpose of the Study:
- To review recent developments in machine learning-based antibody discovery and optimization.
- To compare ML methods with traditional approaches.
- To explore future directions and ethical considerations.
Main Methods:
- Review of current literature on ML in antibody design.
- Analysis of ML model capabilities for in silico antibody generation.
- Discussion of time and cost efficiencies.
Main Results:
- ML models enable rapid, in silico antibody design.
- Significant reductions in time (approx. 60%) and cost (approx. 50%) are achievable.
- ML shows promise in overcoming limitations of traditional methods.
Conclusions:
- Machine learning is transforming antibody discovery and optimization.
- Future research should focus on AI agents and data infrastructure.
- Ethical and regulatory frameworks are vital for ML adoption.
Keywords:
antibody developabilityantibody engineeringantibody–antigen interactioncomputational antibody designmachine learning
